Walgreens Boots Alliance, Inc. with ticker code (WBA) now have 16 analysts in total covering the stock. The consensus rating is pointing to ‘hold’. The target price High/Low ranges between $35.00 and $18.00 with the average target price sitting at $23.02. Given that the stocks previous close was at $17.85 this indicates there is a potential upside of 29.0%. The 50 day MA is $20.84 while the 200 day moving average is $23.50. The company has a market cap of 15.23B. The stock price for the company is currently is currently $17.65 USD
The potential market cap would be $19,637,135,680 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of $167.54 and a 1.12% return on assets.
Walgreens Boots Alliance, Inc. is an integrated healthcare, pharmacy and retailing company. The Company operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The Company’s U.S. Retail Pharmacy segment includes the Walgreens business, which includes the operations of retail drug stores, health and wellness services, and specialty and home delivery pharmacy services, and its equity method investment in AmerisourceBergen. Its International segment consists of pharmacy-led health and beauty retail businesses outside the United States and a pharmaceutical wholesaling and distribution business in Germany. Its portfolio of consumer brands include Walgreens, Boots, Duane Reade, the No7 Beauty Company, Benavides in Mexico and Ahumada in Chile. Its U.S. Healthcare segment is a consumer-centric, technology-enabled healthcare business that engages consumers through a personalized, omni-channel experience across the care journey.
